Skip to main content
. 2020 Jan 28;10:1332. doi: 10.1038/s41598-020-57930-x

Figure 5.

Figure 5

Progression-free survival (PFS) during first line palliative chemotherapy in patients with an elevation of CA19-9 prior to detection of cancer recurrence (red line) versus PFS of patients with no prior CA19-9 elevation. The p-value is 0.008.